👐 The Human Technopole's National Facilities are now open to the national scientific community! External users affiliated with universities, IRCCS, and public research entities can access our state-of-the-art technological hubs for free through open calls 👉 https://lnkd.in/d49j-WUX 🔬 HT National Facilities offer open access to cutting-edge technologies in the fields of genomics, genome engineering and disease modelling, imaging, structural biology, and data handling and analysis. 👩🔬 👨🔬 Our mission is to support the scientific community by providing access to advanced technologies and expertise, training programmes, and technology/method development projects, with the ultimate goal of increasing the impact of Italian research on an international level. 🔎 Access is granted based on the principles of scientific excellence, with the aim of supporting high-quality research. Watch the video to discover the access modalities and timelines.
Human Technopole
Servizi di ricerca
Milan, Lombardy 37.797 follower
Il nuovo istituto italiano di ricerca per le Scienze della Vita, situato nel cuore di MIND.
Chi siamo
- Sito Web
-
https://humantechnopole.it/en/
Link esterno per Human Technopole
- Settore
- Servizi di ricerca
- Dimensioni dell’azienda
- 201-500 dipendenti
- Sede principale
- Milan, Lombardy
- Tipo
- Non profit
- Data di fondazione
- 2018
- Settori di competenza
- Genomics, Proteomics, Metabolomics, Metagenomics, Imaging, DataScience, Bioinformatics, Immunology, Cancer, Neurobiology, Neurodegeneration, Nutrition, Agriculture, Food, Nanomaterials, Nanotechnology, Network Pharmacology, High Performance Computing, Economics, Society, Health e Life Sciences
Località
-
Principale
Viale Rita Levi-Montalcini, 1
Milan, Lombardy 20157, IT
Dipendenti presso Human Technopole
-
Piero Carninci
Head of Genomics Research Center, Functional Genomics Programme at Human Technopole
-
Gianmario Verona
Gianmario Verona è un influencer Fondazione Romeo ed Enrica Invernizzi Professor of Innovation Management at Università Bocconi, Chairman at Fondazione Human Technopole
-
Carlos Fernández San Millán
Executive, CIO | Head of ICT & Digitisation
-
Luisa Zuccolo
Aggiornamenti
-
🌟 Join us at the Neurogenomics Conference at Human Technopole, Milan, taking place 19–21 May 2025. Featuring an outstanding lineup of global experts, this event promises vibrant discussions, keynote lectures, and invaluable networking opportunities. Whether you’re an established researcher or an emerging talent, this conference offers an unparalleled opportunity to stay at the forefront of neurogenomics and foster international collaborations. Register by 31 Mar 👉 https://lnkd.in/g5vJ8t3Y 📢 Submit your abstract by 31 Mar for the chance to present your work through a talk or poster and don’t miss the "Meet the Speaker" sessions to connect with world-class experts! Jose Davila-Velderrain Research Group Leader, HT Oliver Harschnitz Research Group Leader, HT Nereo Kalebic Research Group Leader, HT Elena Taverna Research Group Leader, HT Giuseppe Testa Head of Neurogenomics, HT Ido Amit Weizmann Institute of Science Elisabeth Binder Max Planck Institute of Psychiatry Cedric Boeckx Catalan Institute for Advanced Studies (ICREA), Universitat de Barcelona Boyan Bonev Helmholtz Pioneer Campus Thomas Bourgeron Institut Pasteur, Université de Paris Silvia Cappello Ludwig Maximilian University of Munich – LMU Gonçalo Castelo Branco Karolinska Institutet Matthew Cobb The University of Manchester Sally Cowley University of Oxford Bart De Strooper VIB-KU Leuven Center for Brain & Disease Research Aleksandra Deczkowska Institut Pasteur Daniel Geschwind UCLA Florent Ginhoux Agency for Science, Technology and Research (A*STAR) Yukiko Gotoh University of Tokyo Baasem Hassan Institut du Cerveau Wieland B. Huttner Max Planck Institute of Molecular Cell Biology and Genetics Lodato Simona Humanitas Research Centre Claire Magnon Laboratory of Cancer and Microenvironment-National Institute of Health and Medical Research (INSERM), Institute of Biology François Jacob-Atomic Energy Commission (CEA), University of Paris Cité, University of Paris-Saclay, Guo-li Ming Perelman School of Medicine, University of Pennsylvania Tom Nowakowski University of California San Francisco Sergiu P. Pașca Stanford University Armin Raznahan Section on Developmental Neurogenomics, National Institute of Mental Health Hongjun Song, Ph.D. Perelman School of Medicine, University of Pennsylvania Elly Tanaka Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) Roberto Toro Institut Pasteur Pierre Vanderhaeghen VIB Center for Brain and Disease Research, Leuven Brain Institute, KULeuven Varun Venkataramani German Cancer Research Center (DKFZ), University Hospital Heidelberg
-
😉 Join us for the 1st workshop on Data Science for Health and Biology #DS4HB with 3 days of plenary talks, hands-on tutorials & networking! Organized by Politecnico di Milano and the Health Data Science Centre at Human Technopole, DS4HB provides a platform for researchers, clinicians, and biologists to explore innovations that will shape the future of healthcare and personalized medicine. 👉 https://lnkd.in/dpMkfnqy
-
-
🧠 New research from our Giuseppe Testa Group sheds light on Gabriele-de Vries Syndrome, a rare neurodevelopmental disorder. Individuals with GADEVS exhibit developmental delay, intellectual disabilities, craniofacial abnormalities, and skeletal and cardiovascular issues, among others. 🔬 Using advanced stem cell models, the team reveals how YY1 mutations disrupt brain development, offering new insights into potential treatments. Published in the Nature Portfolio journal Molecular Psychiatry.
-
💜 Gender equality is fundamental to excel in research and innovation! 🎉 On International Women's Day #IWD2025, we are proud to present our new Gender Equality Plan. This plan strengthens our commitment to gender equality in research and the workplace, fostering inclusivity and excellence. ✔ We are also proud to have obtained the UNI/PdR 125:2022 certification, recognising our efforts in promoting gender equality. 🌈 By integrating gender perspectives into our policies, research, and workplace culture, we aim to create a more equitable future for all. Read more 👉 https://lnkd.in/dBKNgmPc
-
-
🧬 Can AI and advanced learning help us decode cancer? Human Technopole offers 2 fully funded 4-year PhD fellowships in Computational Biology through SISSA focusing on AI for spatial cancer biology in the Andrea Sottoriva Group and Unsupervised learning for cancer pathway reconstruction in the Francesco Iorio Group. 📅 Deadline: 23 May 2025 👉 https://lnkd.in/dDD6b5Ny
-
-
🚀 We are excited to announce the first 2025 event of the HT External Seminar Series, featuring an exceptional guest! Kai Simons, Emeritus Director of the MPI-CBG - Max Planck Institute of Molecular Cell Biology and Genetics and CEO of Lipotype GmbH, will give a talk on "Quantitative lipidomics as a novel fingerprint of health and disease". 🔬 Kai Simons has received numerous accolades, including lectureships from esteemed scientific societies and internationally renowned academic institutions. His recent research has focused on cell membrane organisation and function. He pioneered the concept of lipid rafts as a membrane organising principle, based on the phase-separating capabilities of sphingolipids and cholesterol in cell membranes. Sign up now 👉 https://lnkd.in/dbrpMNQy
-
-
🔬 New research from our Francesca Coscia (Group Leader, Structural Biology), the Università degli Studi di Milano-Bicocca and Università degli Studi di Milano reveals key insights into thyroxine synthesis. 🦋 Researchers found that an acidic amino acid next to the hormonogenic tyrosine in thyroglobulin is essential for thyroxine production. This discovery sheds light on thyroid hormone biochemistry and could lead to improved treatments for hypothyroidism and hyperthyroidism. The study, published in The Journal of Biological Chemistry and featured on the February cover, highlights how small changes in protein structure impact hormone synthesis.
-
👨👩👧👦 Over 30 million people in Europe and 300 million worldwide live with a rare disease. Despite their great overall number, rare disease patients are the orphans of health systems, often denied diagnosis and treatment. 🔬 At Human Technopole, we believe in the power of research to drive change. Through a multi-scale systems biology approach, state-of-the-art facilities and cutting-edge experimental and computational research, we aim to deepen our understanding of these conditions and contribute to future personalised medicine. ✨ On this World #RareDiseaseDay, we stand with researchers, healthcare professionals, patients, and families who face these challenges every day. Because rare diseases are not so rare — and together, we are making a difference.